Other
19 Authors
- Smith AL,
- Ross HS,
- Neale G,
- Vogel P,
- Kundu M,
- Valentine M,
- Li-Harms X,
- Ni M,
- Wright CW,
- Pareek G,
- Kaminski MM,
- Wu H,
- Sheth A,
- Pounds S,
- Lynch J,
- Schuetz JD,
- Lu J,
- Wang YD,
- Fukuda Y
| First Author | Li-Harms X | Year | 2025 |
| Journal | Sci Adv | Volume | 11 |
| Issue | 1 | Pages | eads8489 |
| PubMed ID | 39742470 | Mgi Jnum | J:364856 |
| Mgi Id | MGI:7798376 | Doi | 10.1126/sciadv.ads8489 |
| Citation | Li-Harms X, et al. (2025) Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis. Sci Adv 11(1):eads8489 |
| abstractText | The role of somatic mitochondrial DNA (mtDNA) mutations in leukemogenesis remains poorly characterized. To determine the impact of somatic mtDNA mutations on this process, we assessed the leukemogenic potential of hematopoietic progenitor cells (HPCs) from mtDNA mutator mice (Polg D257A) with or without NMyc overexpression. We observed a higher incidence of spontaneous leukemogenesis in recipients transplanted with heterozygous Polg HPCs and a lower incidence of NMyc-driven leukemia in those with homozygous Polg HPCs compared to controls. Although mtDNA mutations in heterozygous and homozygous HPCs caused similar baseline impairments in mitochondrial function, only heterozygous HPCs responded to and supported altered metabolic demands associated with NMyc overexpression. Homozygous HPCs showed altered glucose utilization with pyruvate dehydrogenase inhibition due to increased phosphorylation, exacerbated by NMyc overexpression. The impaired growth of NMyc-expressing homozygous HPCs was partially rescued by inhibiting pyruvate dehydrogenase kinase, highlighting a relationship between mtDNA mutation burden and metabolic plasticity in leukemogenesis. |
